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Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol R J Playford, J J Batten, T C Freeman, K Beardshall, D A Vesey, G C Fenn, J H Baron, J Calam Abstract Pancreatic secretory trypsin inhibitor (PSTI) is a potent protease inhibitor that also has growth promoting activity. It has recently been identified in the foveolar cells of the stomach, which secrete mucus. We examined the effects of the prostaglandin E1 analogue misoprostol on gastric PSTI output. Seven normal volunteers took part. An initial period ofgastric aspiration was followed by four 40 minute periods of gastric perfusion at 5 ml/minute of: 0-14 molll saline, 0.17 mmol/l bicarbonate, bicarbonate with misoprostol 400 rig, and then bicarbonate again. All perfusates contained polyethylene glycol 4000 as a marker. Misoprostol increased median gastric secretion of PSTI from 11 to 33 ig/hour (p<005), producing concentrations in gastric juice six times higher than those found in jejunal juice and about 1/30 of the values seen in pancreatic juice. Median mucus secretion increased to a lesser extent from 29 to 38 mg/hour during misoprostol. There was no change in intragastric concentrations of protein or of epidermal growth factor during infusion of misoprostol. Infusion of pentagastrin (6 iglkg/ hour) had no effect on gastric secretion of mucus, PSTI, or protein. Human gastric mucus was degraded on incubation with trypsin in vitro and this was prevented by the addition of PSTI. These results suggest that gastric PSTI may protect the gastric mucus layer against refluxed pancreatic proteases. Increased output of PSTI during microprostol may contribute to the protective effect of this drug.
Pancreatic secretory trypsin inhibitor (PSTI) is a potent inhibitor of trypsin and chymotrypsin' that has recently been found in the foveolar cells of the stomach as well as in the pancreas.2 3 The foveolar cells also secrete mucus,4 which helps to create the protective gastric mucus layer. 5 We therefore speculated that PSTI may protect the gastric mucus layer from damage by pancreatic proteases that reflux into the stomach in normal people and, to a greater extent, in diseases including chronic gastric ulcer.6 Because the prostaglandin E1 analogue misoprostol heals gastric ulcers7 and increases the concentration of mucus in gastric juice,8 we examined its effect on the gastric output of PSTI.
When considering the proposed protective effect of PSTI against pancreatic enzymes, it is important to note that both PSTI and trypsin are digested by pepsin, but only at a low pH.9'0 Pepsin, however, is inactive against trypsin and PSTI at pH values >4'°-values that occur normally within the mucus layer5 and in the lumen when acid secretion is reduced by disease or drugs," 12 buffered by food, or neutralised by refluxed duodenal juice. 3 We therefore measured gastric PSTI both before and during intragastric neutralisation with bicarbonate. Epidermal growth factor was measured as a control protein of similar size to PSTI, present in gastric juice, but principally of salivary origin. '4 The effect of pentagastrin on gastric secretion of mucus was also investigated because pentagastrin has been reported to increase mucus secretion in the cat,'5 but to decrease it in man. 16 Subjects and methods
ETHICS
The study protocols were approved by the local ethics committee and all patients and volunteers gave informed consent. EFFECT (Fig 1) . Four subjects had a repeat study one week later with two stages of 40 minutes each -aspiration only followed by saline perfusion and then an 80 minute perfusion with 0. 17 mol/l sodium bicarbonate (Fig 1) . w (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) , 15 (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) , and 10 (5-14) p.g/hour, and rates of mucus output were 32 (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) , 31 (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) , and 29 (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) mg/hour before, during, and after pentagastrin respectively. The pH of the aspirates was never less than 7-2 during the study. (Fig 2A) . In the presence of PSTI, however, 90% of mucus carbohydrate eluted at Vo, the characteristic position of native gastric mucus glycoprotein (Fig 2B) .
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EFFECT OF TRYPSIN ON HUMAN GASTRIC MUCUS IN VITRO

ANALYSIS OF DUODENAL JUICE
Median (range) concentrations in duodenal aspirates were PSTI, 30 Discussion These studies show the first time that a therapeutic dose of the synthetic prostaglandin El derivative misoprostol increases gastric output of PSTI, and that PSTI can protect gastric mucus from damage by trypsin.
The protocol was based on knowledge of the nature of PSTI. Firstly, PSTI is destroyed by pepsin at pH <4,10 so bicarbonate was used to keep the intragastric pH neutral during the last three test periods. The effect ofthis was tested by comparing measured PSTI output during administration of saline v bicarbonate. Secondly gastric perfusion might 'wash' PSTI out of the mucus layer. Therefore the stomach was perfused at a constant rate during the last four test periods. Also at acid pH, increased volume flow might decrease peptic hydrolysis by diminishing the time between its secretion and collection. To examine this we compared measured output between simple aspiration and saline perfusion. The results that we obtained are consistent with these ideas (Fig 1) . There was a small transient rise in measured PSTI output during saline perfusion v simple aspiration, a further significant rise when the perfusate was changed from saline to bicarbonate and a more substantial rise on the addition of misoprostol to bicarbonate. The latter increase did not occur when misoprostol was omitted during this time period in four subjects, indicating that the response was to misoprostol rather than to prolonged perfu- Pentagastrin did not increase measured gastric PSTI output in the present study, although the same dose of pentagastrin did do so in our previous study which was based on simple aspiration of gastric juice."' The difference probably reflects the different method used to collect gastric juice, as discussed above. During simple aspiration, pentagastrin stimulated volume flow may have 'washed' PSTI out of the mucus layer and reduced the duration of its exposure to acid pepsin. Gastric perfusion with bicarbonate may have reduced these effects in the present study. An increase in lumenal mucus during pentagastrin stimulation in the cat'" may also have been caused by 'washout'.
PSTI stimulates the growth of some normal and neoplastic cells,2930 at concentrations similar to those found in gastric juice.29 PSTI may therefore affect gastric epithelial growth and play a role in the stimulation ofepithelial proliferation by misoprostol.3' Bronchial, nasal, and seminal mucus secretions all contain protease inhibitors,32 presumably to prevent proteolytic digestion of the mucus. Deficiency of a 1 antitrypsin in the respiratory tract causes emphysema,33 probably through uninhibited tissue proteases. We propose that gastric PSTI may similarly protect the stomach. Further studies are required to examine its possible role in gastric disease.
